Jeremy Larsen, MD
Associate Professor, UNMC Division of Hematology
Jeremy Larsen, MD, is a board-certified hematologist and physician-scientist specializing in blood disorders and hematologic malignancies. He earned his medical degree from Creighton University School of Medicine in Omaha and completed his internal medicine residency and hematology/oncology fellowship at the Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.
Dr. Larsen’s clinical focus includes multiple myeloma, amyloidosis, Waldenström macroglobulinemia, MGUS and non-malignant blood disorders. He is deeply engaged in advancing patient care through clinical research, with particular interest in novel immunotherapies, biomarker-driven treatment strategies and outcomes research in plasma cell disorders.
Dr. Larsen has authored and co-authored numerous peer-reviewed publications in leading hematology and oncology journals. His work includes early-phase and first-in-human studies of BCMA-targeted therapies, investigations into minimal residual disease and prognostic biomarkers, and studies evaluating treatment outcomes in multiple myeloma and amyloidosis. Dr. Larsen is recognized for his patient-centered approach and commitment to integrating cutting-edge research into clinical practice.
Information
- Medical School: Creighton University School of Medicine, 2009
- Residency: Mayo Clinic School of Graduate Medical Education, 2012
- Fellowship: Hematology/Oncology, Mayo Clinic School of Graduate Medical Education, 2016
Hospital Appointments: Nebraska Medicine
Clinic Locations: Fred & Pamela Buffett Cancer Center - Nebraska Medical Center; Fred & Pamela Buffett Cancer Center - Village Pointe Health Center
Department of Internal Medicine
College of Medicine
University of Nebraska Medical Center
986840 Nebraska Medical Center
Omaha, NE 68198-6840